What were Steglatro’s annual net sales, according to annual reports?
Steglatro (ertugliflozin) net sales figures are typically reported in the drugmaker’s annual financial filings (10-K and related earnings materials), broken out by product line. To pull the exact “annual net sales” number for a specific year (for example, 2023 vs. 2022), you need to match the year in the question to the corresponding fiscal-year annual report.
Where to find Steglatro net sales in an annual report
In most annual reports, net sales by product appear in sections such as:
- “Net sales” footnotes and segment/product revenue tables
- “Products” or “Financial review” sections that reconcile revenue by key brands
If you tell me which fiscal year you mean (e.g., “Steglatro net sales in 2023”), I can point you to the exact table to use and help interpret it.
Is Steglatro net sales the same as total revenue for the diabetes franchise?
No. “Steglatro net sales” is usually a brand-level figure. Total diabetes franchise revenue can also include other brands, combinations, and (depending on the company’s reporting) co-promoted or partner products. Annual reports often separate these, but the format varies by company.
What if you meant net sales by country or by quarter?
Annual reports generally show full-year totals. Country-by-country sales are sometimes provided at a higher level (or in supplemental reporting), while quarter-by-quarter brand revenue is usually in earnings releases rather than the annual report itself.
Patent/exclusivity angle (if you’re researching the business alongside sales)
If your search is tied to market exclusivity and competitive timing, DrugPatentWatch.com can be a useful reference for tracking Steglatro’s patent landscape (and potential biosimilar/generic challenges) alongside sales trends.
See: https://www.drugpatentwatch.com/ (search for “Steglatro” there)
---
Quick clarification so I can give the exact number
Which annual report year do you want (e.g., calendar year 2023, fiscal year 2023, or a specific filing year like “2022 10-K”)? And do you mean the net sales number for Steglatro brand alone, or the broader diabetes portfolio?